Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Primary immunodeficiency 💬
1件: BTK 💬 Acalabrutinib 💬 Acalabrutinib 2件: 46, 61 💬
2 Primary immunodeficiency 💬
1件: BTK 💬 Branebrutinib 💬 Branebrutinib 3件: 46, 49, 53 💬
3 Primary immunodeficiency 💬
1件: BTK 💬 Evobrutinib 💬 Evobrutinib 3件: 13, 46, 49 💬
4 Primary immunodeficiency 💬
1件: BTK 💬 Fenebrutinib 💬 Fenebrutinib 1件: 13 💬
5 Primary immunodeficiency 💬
1件: BTK 💬 Ibrutinib 💬 Ibrutinib 3件: 28, 60, 61 💬
6 Primary immunodeficiency 💬
1件: BTK 💬 Orelabrutinib 💬 Orelabrutinib 4件: 13, 49, 61, 63 💬
7 Primary immunodeficiency 💬
1件: BTK 💬 Remibrutinib 💬 Remibrutinib 2件: 13, 53 💬
8 Primary immunodeficiency 💬
1件: BTK 💬 Zanubrutinib 💬 Zanubrutinib 5件: 13, 63, 222, 300, 331 💬
9 Primary immunodeficiency 💬
1件: CD19 💬 Inebilizumab 💬 Inebilizumab 4件: 11, 13, 51, 300 💬
10 Primary immunodeficiency 💬
1件: CD19 💬 Obexelimab 💬 Obexelimab 1件: 300 💬
11 Primary immunodeficiency 💬
2件: CD3D, CD3E 💬 Otelixizumab 💬 Otelixizumab 1件: 46 💬
12 Primary immunodeficiency 💬
2件: CD3D, CD3E 💬 Visilizumab 💬 Visilizumab 2件: 96, 97 💬
13 Primary immunodeficiency 💬
1件: CD3E 💬 Mosunetuzumab 💬 Mosunetuzumab 1件: 49 💬
14 Primary immunodeficiency 💬
1件: CD4 💬 Zanolimumab 💬 Zanolimumab 1件: 46 💬
15 Primary immunodeficiency 💬
1件: CD40 💬 Bleselumab 💬 Bleselumab 1件: 222 💬
16 Primary immunodeficiency 💬
1件: CD40 💬 Iscalimab 💬 Iscalimab 2件: 49, 53 💬
17 Primary immunodeficiency 💬
1件: CD40 💬 Ravagalimab 💬 Ravagalimab 2件: 53, 97 💬
18 Primary immunodeficiency 💬
1件: CD40LG 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
19 Primary immunodeficiency 💬
1件: IL2RG 💬 Aldesleukin 💬 Aldesleukin 6件:  2 , 35, 49, 65, 96, 97 💬
20 Primary immunodeficiency 💬
1件: JAK3 💬 Peficitinib 💬 Peficitinib 1件: 46 💬
21 Primary immunodeficiency 💬
1件: JAK3 💬 Tofacitinib 💬 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 💬
22 Primary immunodeficiency 💬
1件: LCK 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
23 Primary immunodeficiency 💬
1件: LCK 💬 Dasatinib 💬 Dasatinib 2件: 51, 85 💬
24 Primary immunodeficiency 💬
1件: TNFRSF13C 💬 Ianalumab 💬 Ianalumab 7件: 35, 46, 49, 53, 61, 63, 95 💬